XRP Adoption Expands to 6,000 US Pharmacies in $50M Deal

XRP is gaining further traction as Wellgistics Health announces a groundbreaking initiative to implement XRP payments across over 6,000 independent pharmacies throughout the United States. This move is part of a broader $50 million financial strategy focused on incorporating blockchain-based solutions into the healthcare supply chain.

Wellgistics, a Florida-based pharmaceutical distribution and technology company, is establishing a $50 million equity capital facility facilitated by private investment firm LDA Capital. This funding structure enables Wellgistics to draw funds incrementally when needed, and it has chosen XRP to serve as both a reserve asset and the primary medium for settlement within its pharmacy network and ecosystem of more than 150 drug manufacturers nationwide.

Unlike conventional banking methods, like ACH transfers which can take several days, XRP’s blockchain infrastructure allows for instant transactions and ultra-low fees—fundamentally changing how pharmaceutical payments and rebates are processed. The deployment leverages the XRP Ledger (XRPL) to facilitate direct and rapid transfers, minimizing operational delays and enhancing liquidity flows between pharmacies, distributors, and suppliers. This approach is aimed at ensuring real-time credit management and accelerating rebate settlements within the ecosystem.

Brian Norton, CEO of Wellgistics Health, emphasized that the healthcare sector must move beyond legacy systems that are often slow and cumbersome. “We’re building a future where finance in healthcare doesn’t have to lag behind,” he stated. He believes the integration of blockchain-based payments powered by XRP positions the company at the convergence of healthcare efficiency and fintech innovation.

Mark DiSiena, Chief Financial Officer at Wellgistics, also commented on the benefits of using XRP for this initiative. He described the setup as one designed to “unlock the velocity of capital with surgical precision,” underlining the positive financial implications of blockchain-based treasury infrastructure within the organization.

This announcement comes amid growing developments in the ecosystem of XRP as an institutional asset. Notably, financial derivatives marketplace CME Group is preparing to debut cash-settled XRP futures contracts on May 19. These contracts will be offered in two sizes—micro contracts at 2,500 XRP and standard contracts at 50,000 XRP. This regulated exposure to XRP is likely to enhance liquidity and support formal price discovery, potentially improving mainstream confidence in XRP as a corporate asset class.

While the futures market and Wellgistics’ operational deployment remain independent initiatives, their cumulative effect could significantly elevate XRP’s status among enterprise-grade digital assets. The timing appears strategic, with more U.S. institutions leaning into blockchain solutions amid gradually warming regulatory sentiment in Washington. Despite ongoing legal ambiguity surrounding XRP’s classification under securities law, recent developments suggest an increasingly favorable environment for corporate adoption.

It’s important to note that the full drawdown schedule for Wellgistics’ equity facility has not been disclosed, nor has the precise timeline for when XRP payments will be fully operationalized across its extensive pharmacy network. Furthermore, the prospect of equity dilution remains a possibility depending on the extent of share issuances under this funding mechanism.

As Wellgistics transitions key elements of its treasury reserves and payment infrastructure onto a decentralized ledger, it joins a growing list of companies seeking to digitize workflows and capital processes. In doing so, it opens a new chapter for both the healthcare sector and the broader quest to integrate blockchain into critical real-world industries.

This initiative also aligns with the company’s broader pivot toward therapeutic specialties, including treatments related to GLP-1 medications and post-COVID care, signaling an overarching strategy that combines innovation in logistics, finance, and patient-focused services.

Related: Expert Advice: Sell XRP If You’re Confused

By leveraging XRP, Wellgistics is not only optimizing the performance of its supply chain but also taking a decisive step toward building healthcare infrastructure that’s faster, leaner, and more resilient in today’s digitally driven economy.